Circle | Preliminary Core Set OMERACT 2016 | Proposed Core Set OMERACT 2018 | Final Approved Core Set OMERACT 2018 | Delphi§,9 | Confidence in the Evidence from Qualitative Evidence Synthesis±,10 |
---|---|---|---|---|---|
Inner | Pain | Pain | Pain | 97% | Moderate |
Physical function/activity | Physical function/activity | Physical function/activity | 94% | Moderate | |
Global perceived effect | Global perceived effect | Patient global — shoulder | 86% | NA | |
Adverse events | Adverse events including death | Adverse events including death | NA | NA | |
Middle | Participation (recreation and work) | Participation (recreation and work) | Participation (recreation and work) | NA; work ability 90%; recreation 71% | Moderate |
Sleep | Sleep | Sleep | 70% | Moderate | |
Emotional well-being | Emotional well-being | Emotional well-being | 69% | Moderate/low* | |
— | Condition-specific pathophysiological manifestations | Condition-specific pathophysiological manifestations | Voted out (< 67%) | Low | |
Outer | Research agenda | Cognitive dysfunction | NA | Very low |
↵§ Percentage of votes from the Delphi second round agreeing with the inclusion of the domain9.
↵± Confidence in each review finding (high, moderate, low, very low) using the GRADE-CERQual approach11; data from the qualitative evidence synthesis10.
↵* Moderate for frustration and anxiety and low for depression. OMERACT: Outcome Measures in Rheumatology; NA: not available, i.e., not included in the Delphi or in the qualitative evidence synthesis; GRADE-CERQual: Confidence in the Evidence from Reviews of Qualitative research.